Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies
Joe N. Kornegay(Texas A&M University), Daniel J. Bogan(University of North Carolina at Chapel Hill), Martin K. Childers(University of Washington), Robert W. Grange(Virginia Tech), Bruce P. Keene(North Carolina State University), James F. Howard(University of North Carolina at Chapel Hill), Ratna Bhavaraju‐Sanka(The University of Texas Health Science Center at San Antonio), Kevin M. Flanigan(Nationwide Children's Hospital), C.A. Larsen(University of Utah), Martin Styner(University of North Carolina at Chapel Hill), Peter P. Nghiem(Texas A&M University), Zheng Fan(Nanyang Technological University), Scott J. Schatzberg(Georgia College & State University), Eric P. Hoffman(Binghamton University), Juan Li, Jiahui Wang(Qingdao Agricultural University), Xiao Xiao(University of North Carolina at Chapel Hill), Janet R. Bogan(University of North Carolina at Chapel Hill), Sandra Tou(North Carolina State University), David A. Detwiler(University of North Carolina at Chapel Hill)
Cited by 0
Related Papers
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
|The Lancet Neurology|2017|820
Evidence‐based path to newborn screening for duchenne muscular dystrophy
|Annals of Neurology|2012|816
Eteplirsen for the treatment of Duchenne muscular dystrophy
|Annals of Neurology|2013|793
Dystrophin Immunity in Duchenne's Muscular Dystrophy
|New England Journal of Medicine|2010|655
Distinctive patterns of microRNA expression in primary muscular disorders
|Proceedings of the National Academy of Sciences|2007|509